Navigation Links
National Eye Institute Launches Ancillary Study to AREDS2 With ForeseeHome(TM) AMD Monitor
Date:6/15/2010

ST. LOUIS, June 15 /PRNewswire/ -- The National Eye Institute, of the U.S. National Institutes of Health, announced the launch of an ancillary study to the ongoing Age-Related Eye Disease Study 2 (AREDS2).  AREDS2 is a nationwide study of 4,000 individuals at moderate to high risk for developing age-related macular degeneration (AMD) to determine whether oral supplementation of lutein/zeaxanthin and omega-3 fatty acids can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.

The objective of this ancillary study is to determine if home monitoring using the ForeseeHome™ AMD Monitor would lead to earlier detection of wet AMD when compared with standard care, and result in better visual acuity following therapy at one year.

The ForeseeHome™ AMD Monitor is the first ophthalmic device designed to provide ongoing monitoring of patients with AMD between visits to their eye care professional.  Patients complete a brief exam on their ForeseeHome™ AMD Monitor in the comfort of their own home, and data are transmitted to the Notal Vision Data Monitoring Center.  The award winning ergonomic design of the ForeseeHome™ AMD Monitor is comfortable and easy to use for patients at risk of vision loss from AMD.

Notal Vision was founded by a team of medical professionals determined to develop better methods of AMD monitoring and reduce vision loss associated with AMD. For more information, please visit www.notalvision.com.

The National Eye Institute (NEI) is part of the National Institutes of Health (NIH) and is the Federal government's lead agency for vision research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. For more information, visit the NEI Website at http://www.nei.nih.gov/.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.


'/>"/>
SOURCE Notal Vision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
2. Veteran International Health Care Executive Appointed CEO of BeneChill(R)
3. Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound
4. AstraZeneca to Support Drug-Induced Liver Injury Network at the National Institutes of Health
5. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
6. HealthWarehouse.com Receives VIPPS Accreditation From The National Association of Boards of Pharmacy
7. National Anesthesia Services, Inc. Celebrates 21 Years of Dynamic Growth and Achievement
8. Systech International and Videojet Brazil Partner to Meet Brazils Emerging Pharmaceutical Regulatory Requirements
9. Drug Production in Afghanistan: A Challenge for the International Community
10. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
11. OXIS International, Inc. Announces Its Attendance at the Rodman & Renshaw Annual Global Investment Conference in London, May 16-18, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 On ... Committee honored excellence in research, development and innovation in ... gala dinner was held in the presence of Sergey ... Russian Federation , Natalia Sanina, First ... Mikhail Murashko , Head of Roszdravnadzor, National Service of ...
(Date:12/2/2016)... CVS Health Corporation (NYSE: CVS ... City on Thursday, December 15, 2016, beginning at 8:00 a.m. (ET). Senior ... an in-depth review of the company,s strategies to drive ... also discuss 2017 earnings guidance during the event. ... will be broadcast simultaneously on the Investor Relations portion ...
(Date:12/2/2016)... -- On Thursday, the NASDAQ Composite and the ... Dow Jones Industrial Average managed to stay in green. Losses ... prompted Stock-callers this morning to look at the performances of ... ), Smith & Nephew PLC (NYSE: SNN ), ... Therapeutics Inc. (NASDAQ: KOOL ). You can access ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global law ... 21st Drug & Medical Device Litigation Conference , taking place in New York Dec. ... chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the Trial ...
(Date:12/2/2016)... ... , ... Advanced Inc., a leading provider of travel therapy and travel nursing ... as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as ... operational leadership experience to Advanced Inc. He began his career in finance at Ernst ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with constant ... works for them. When an inventor from Suisun City, Calif., was unsuccessful in finding ... it with others. , He developed a prototype for PRO GO MASSAGE to relieve ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a ... SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories ... and disposal. The new version is a faster and a more efficient product, ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):